nach oben

Erschienen in:

01.12.2011 | SIN Document

Recommendations for the management of urinary disorders in multiple sclerosis: a consensus of the Italian Multiple Sclerosis Study Group

verfasst von: A. Ghezzi, R. Carone, G. Del Popolo, M. P. Amato, A. Bertolotto, M. Comola, U. Del Carro, P. Di Benedetto, A. Giannantoni, M. L. Lopes de Carvalho, E. Montanari, F. Patti, A. Protti, S. Rasia, A. Salonia, C. Scandellari, F. Sperli, M. Spinelli, C. Solaro, A. Uccelli, M. Zaffaroni, V. Zipoli, The Multiple Sclerosis Study Group, Italian Society of Neurology

Erschienen in: Neurological Sciences | Ausgabe 6/2011

Einloggen, um Zugang zu erhalten

Abstract

Urinary disorders are uncommon in the initial phases of multiple sclerosis, but increase in frequency as the disease progresses, with a negative impact on quality of life. The goal of this study was to propose a protocol for the diagnosis and treatment of urinary disorders in multiple sclerosis, based on data from the scientific literature and the experience of Italian clinical centres. In particular, the following clinical aspects were considered: what to do with patients with asymptomatic multiple sclerosis; what to do with symptomatic patients; how and when to perform a second-level diagnostic evaluation; and how to treat urinary disorders. A diagnostic–therapeutic algorithm is proposed, that can be applied in Italian clinical centres.

De Sèze M, Ruffion A, Denys P et al (2007) The neurogenic bladder in multiple sclerosis: review of the literature and proposal of management guidelines. Mult Scler 13:915–928PubMedCrossRef

Litwiller SE, Frohman EM, Zimmern PE (1999) Multiple sclerosis and the urologist. J Urol 61:743–757

Fowler CJ, Paniker JN, Drake M et al (2009) “A UK consensus on the management of the bladder in multiple sclerosis” J. Neurol Neurosurg Psychiatry 80:470–477

4° Consultazione Internazionale sull’Incontinenza: “Linee Guida sull’incontinenza”—Raccomandazioni ICI 2009—Fondazione Italiana Continenza

Stöhrer M, Blok B, Castro-Diaz D et al (2009) EAU guidelines on neurogenic lower urinary tract dysfunction. Eur Urol 56:81–88PubMedCrossRef

Di Benedetto P, Delneri C, Biasutti E et al (2008) Vesicourethral dysfunction in multiple sclerosis. Initial assessment based on lower urinary tract symptoms and their pathophysiology. Neurol Sci (Suppl 4):S348–S351

Del Popolo G, Panariello G, Del Corso F et al (2008) Diagnosis and therapy for neurogenic bladder dysfunctions in multiple sclerosis patients. Neurol Sci 29(Suppl 4):S352–S355PubMedCrossRef

Motta R, Lopes de Carvalho ML (2008) Management of bladder dysfunction in multiple sclerosis patients: the nurse’s point of view. Neurol Sci 29:S356–S359PubMedCrossRef

Matthews B (1998) Symptoms and signs of multiple sclerosis. In: Compston A et al (eds) McAlpine multiple sclerosis, Churchill Livingstone, London, pp 144–190

10.

Nortvedt MW, Riise T, Frugård J et al (2007) Prevalence of bladder, bowel and sexual problems among multiple sclerosis patients two to five years after diagnosis. Mult Scler 13:106–112PubMedCrossRef

11.

Abrams P, Cardozo L, Fall M et al (2002) The standardisation of terminology of lower urinary tract function: Report from the standardisation sub-committee of International Continence Society. Neurourol Urodyn 21:167–178PubMedCrossRef

12.

Koldewijn EL, Hommes OR, Lemmens WA et al (1995) Relationship between lower urinary tract abnormalities and disease-related parameters in multiple sclerosis. J Urol 154:169–173PubMedCrossRef

13.

Frazer ML, Benson JT, Hashemi CAB et al (2007) Sphincter symptoms as predictors of long-term disability in multiple sclerosis. Arch Neurol 64:1359PubMedCrossRef

14.

Nortvedt MW, Riise T, Myhr KM et al (2001) Reduced quality of life among multiple sclerosis patients with sexual disturbance and bladder dysfunction. Mult Scler 7:231–235PubMed

15.

Kirchhof K, Fowler CJ (2000) The value of the Kurtzke Functional Systems Scales in predicting incomplete bladder emptying. Spinal Cord 38:409–413PubMedCrossRef

16.

Bonniaud V, Bryant D, Parratte B, Guyatt G (2008) Development and validation of the short form of a urinary quality of life questionnaire: SF-Qualiveen. J Urol 180:2592–2598PubMedCrossRef

17.

Karsenty G, Denys P, Amarenco G et al (2008) Botulinum toxin A (Botox) intradetrusor injections in adults with neurogenic detrusor overactivity/neurogenic overactive bladder: a systematic literature review. Eur Urol 53:275–287PubMedCrossRef

18.

Kavia RB, De Ridder D, Constantinescu CS (2010) Randomized controlled trial of Sativex to treat detrusor overactivity in multiple sclerosis. Mult Scler 16:1349–1359PubMedCrossRef

19.

Klaskov P et al (1994) BF treatment of bladder dysfunction in MS—a randomized trial. Scan J Urol Nephrol suppl 157:61–65

20.

Vahtera T et al (1997) Pelvic floor rehabilitation is effective in patients with MS. Clin Rehabil 11:211–219PubMedCrossRef

21.

De Ridder D et al (1999) Pelvic Floor rehabilitation in MS. Acta Neurol Belg 99:61–64PubMed

22.

Krivoborodov GG et al (2002) Afferent stimulation of tibial nerve in patients with hyperactive bladder. Urology 5:36–39

23.

Amarenco G et al (2003) Urodynamic effect of acute transcutaneous posterior tibial nerve stimulation in overactive bladder. J Urol 169:2210–2215PubMedCrossRef

24.

McClurg D et al (2006) Comparison of pelvic muscle training, electromyography biofeedback, and neuromuscular electrical stimulation for bladder dysfunction in people with MS: a randomized pilot study. Neurourol Urodyn 25:337–348PubMedCrossRef

25.

Kabay SC et al (2008) Acute effect of PTNS on neurogenic detrusor overactivity in patients with MS: urodynamic study. Urology 71:641–645PubMedCrossRef

26.

Lopes ML et al (2010) Effectiveness of rehabilitation on urinary disorders in MS. Neurol Sci 31(Suppl.):454

Titel: Recommendations for the management of urinary disorders in multiple sclerosis: a consensus of the Italian Multiple Sclerosis Study Group
verfasst von: A. Ghezzi
R. Carone
G. Del Popolo
M. P. Amato
A. Bertolotto
M. Comola
U. Del Carro
P. Di Benedetto
A. Giannantoni
M. L. Lopes de Carvalho
E. Montanari
F. Patti
A. Protti
S. Rasia
A. Salonia
C. Scandellari
F. Sperli
M. Spinelli
C. Solaro
A. Uccelli
M. Zaffaroni
V. Zipoli
The Multiple Sclerosis Study Group, Italian Society of Neurology
Publikationsdatum: 01.12.2011
Verlag: Springer Milan
Erschienen in: Neurological Sciences / Ausgabe 6/2011
Print ISSN: 1590-1874
Elektronische ISSN: 1590-3478
DOI: https://doi.org/10.1007/s10072-011-0794-y

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

25.04.2024 | Hypotonie | Nachrichten

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Recommendations for the management of urinary disorders in multiple sclerosis: a consensus of the Italian Multiple Sclerosis Study Group

Abstract

Leitlinien kompakt für die Neurologie

Neu im Fachgebiet Neurologie

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Frühe Alzheimertherapie lohnt sich

Viel Bewegung in der Parkinsonforschung

Demenzkranke durch Antipsychotika vielfach gefährdet

Update Neurologie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 6/2011

Posterior cortical atrophy with prominent alexia without agraphia in a Tourette syndrome

Prefibrillar aggregates of yeast prion Sup35NM and its variant are toxic to mammalian cells

Head tremor secondary to MS resolved with rituximab

VGCC antibody-positive paraneoplastic cerebellar degeneration presenting with positioning vertigo

Posterior circulation ischemia in patients with fetal-type circle of Willis and hypoplastic vertebrobasilar system

Marburg’s disease: a diagnostic dilemma

Leitlinien kompakt für die Neurologie

Neu im Fachgebiet Neurologie

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Frühe Alzheimertherapie lohnt sich

Viel Bewegung in der Parkinsonforschung

Demenzkranke durch Antipsychotika vielfach gefährdet

Update Neurologie